Incorrect eTable 9 in Supplement 1 - Summary - MDSpire

Incorrect eTable 9 in Supplement 1

  • June 1, 2026

  • 0 min

Share

Objective:

To correct an error in the supplemental content of the original investigation titled 'SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors,' published online on April 28, 2025.

Key Findings:
  • eTable 9 was published incorrectly as a duplicate of eTable 10 in the original publication.
Interpretation:

The article has been corrected online.

Limitations:
  • No limitations were noted.
Conclusion:

The correction was made to ensure the integrity of the supplemental data.

Original Source(s)

Incorrect eTable 9 in Supplement 1

  • June 1, 2026

Related Content

Autoimmune nodopathy associated with Sjögren’s disease and nephrotic syndrome: a case report and literature review

Predictive value of the uric acid-to-albumin ratio for contrast-induced nephropathy after percutaneous coronary intervention and construction of a clinical prediction model in patients with coronary artery disease

Hyponatremia in patients with severe anorexia nervosa was associated with more severe and longer duration of disease